--Decision follows observation of elevated alanine transaminase (ALT) levels in Phase 2 study--Company will focus on advancing ongoing triple combination studies and earlier pipeline candidates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback